english.prescrire.org > Spotlight > Archives : 2007 > Drug packaging: some progress but still too much unsafe packaging

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2007 : 1 | 30 | 60 | 90

Drug packaging: some progress
but still too much unsafe packaging

A look at well-designed drug packaging shows just how unacceptable poorly designed packaging can be.

In 2006, Prescrire analysed the packaging of 656 drugs and published its review in the February issue of la revue Prescrire and on www.prescrire.org.

The many poorly designed labels remain a major cause for concern, particularly with insufficient prominence given to the International Nonproprietary Name (INN). Many blister packs give too little information, which can lead to a risk of overdose. Too many oral administration devices can generate confusion due to inappropriate graduation.

Patient leaflets vary in their effectiveness in conveying information; some are badly written or the information has not been updated, etc. Many "dosage plans" printed on the packets are confusing and can expose the patient to serious dosage errors.

Many multidose bottles, including for psychotropic drugs, do not have a child-proof closure, exposing patients (children in particular) to serious risks in the event of massive ingestion. On the other hand, some firms have come up with simple, effective and realistic packaging solutions which clearly identify the drug’s name and dosage, with easily understandable patient information and administration devices which are safe and simple to use.

Packaging is an important factor for the good use of drugs. Progress can be made – and progress is needed.

©Prescrire February 2007

Source: "Conditionnement des spécialités pharmaceutiques : encore trop de conditionnements à risques, mais plusieurs initiatives positives" Rev Prescrire 2007 ; 27 (280) : 150 (complete version available online at www.prescrire.org: 11 pages).

- More articles in Prescrire's "Spotlight"...